Table 2 Prevalence (%) of the Pfmdr1 N86 haplotype by period in asymptomatic carriers and clinical cases
N86 | 86Y | 86Y-N86 | 86F-like | |
|---|---|---|---|---|
Asymptomatic carriers | ||||
2005 (before ACT) (N = 51) | 19 (37) | 5 (10) | 11 (22) | 16 (31) |
2007 (ACT implementation) (N = 66) | 0 (0) | 23 (35) | 0 (0) | 43 (65) |
2008–2009 (ITNs scale up) (N = 11) | 0 (0) | 0 (0) | 0 (0) | 11 (100) |
2010–2011 and 2013–2014 (malaria upsurges) (N = 28) | 1 (4) | 1 (4) | 4 (14) | 22 (79) |
Symptomatic (clinical cases) | ||||
2005 (before ACT) (N = 32) | 4 (13) | 16 (50) | 12 (38) | 0 (0) |
2007 (ACT implementation) (N = 84) | 0 (0) | 0(0) | 3 (4) | 81 (96) |
2008–2009 (ITNs scale up) (N = 57) | 0 (0) | 0 (0) | 0 (0) | 57 (100) |
2010–2011 and 2013–2014 (malaria upsurges) (N = 145) | 0 (0) | 0 (0) | 70 (48) | 75 (52) |
All | ||||
2005 (before ACT) (N = 83) | 23 (28) | 21 (25) | 23 (28) | 16 (19) |
2007 (ACT implementation) (N = 150) | 0 (0) | 23 (15) | 3 (2) | 124 (83) |
2008–2009 (ITNs scale up) (N = 68) | 0 (0) | 0 (0) | 0 (0) | 68 (100) |
2010–2011 and 2013–2014 (malaria upsurges) (N = 173) | 1 (1) | 1 (1) | 74 (43) | 97 (56) |